Bernard A, Amor A O, Goemare-Vanneste J, Antoine J L, Lauwerys R, Colin I, Vandeleene B, Lambert A
Unit of Industrial Toxicology, University of Louvain, Brussels, Belgium.
Clin Chim Acta. 1990 Oct 15;190(3):249-62. doi: 10.1016/0009-8981(90)90178-u.
The nature and origin of proteinuria in diabetes mellitus have been investigated by measuring the urinary excretion of seven specific proteins of low (beta 2-microglobin, retinol-binding protein) or high molecular weight (albumin, transferrin, hemopexin and IgG). Using the Alcian Blue binding test, we also measured negative charges on red blood cell (RBC) membrane which according to recent studies might mirror the glomerular polyanion charge. A group of 190 diabetics was examined, including 90 patients with type I diabetes, 23 type II diabetics treated with diet and/or hypoglycaemic agents and 77 longstanding type II diabetics requiring insulin therapy. With the exception of beta 2-microglobulin all proteins measured were excreted in the urine of diabetics in significantly higher amounts than in controls. The assay of transferrin proved the most sensitive (58% positive) followed by albumin (49%), IgG (34%), hemopexin (28%) and retinol-binding protein (26%). Practically the same ranking was obtained when only type I diabetics were considered. RBC membrane negative charges were diminished in diabetics and negatively correlated with the urinary excretion of albumin (r = -0.61, n = 190). RBC charges were also negatively correlated with other urinary proteins of high molecular mass (r between - 0.5 and - 0.2) but presented no relation with urinary beta 2-microglobulin or retinol-binding protein. The loss of RBC charges in diabetics most likely reflects the concomitant depletion of the glomerular polyanion responsible for the increased glomerular leakage of high molecular mass plasma proteins. The preferential increase in transferrin excretion together with the progressive rise in the urinary excretion of IgG lead us to postulate that the loss of glomerular polyanion in diabetes is accompanied, from the early stage, by a progressive decrease in the size-selectivity of the glomerular filter. The urinary excretion of retinol-binding protein was weakly correlated with albuminuria (r = 0.26, n = 186). Eight % of diabetics showed an elevation of urinary retinol-binding protein without evidence of microalbuminuria, which clearly demonstrates that a proximal tubular impairment can occur independently of the glomerular alterations in the course of diabetic nephropathy.
通过测量七种低分子量(β2-微球蛋白、视黄醇结合蛋白)或高分子量(白蛋白、转铁蛋白、血红素结合蛋白和免疫球蛋白G)特定蛋白质的尿排泄量,对糖尿病中蛋白尿的性质和起源进行了研究。使用阿尔新蓝结合试验,我们还测量了红细胞(RBC)膜上的负电荷,根据最近的研究,这可能反映肾小球多阴离子电荷。对一组190名糖尿病患者进行了检查,其中包括90名I型糖尿病患者、23名接受饮食和/或降糖药物治疗的II型糖尿病患者以及77名需要胰岛素治疗的长期II型糖尿病患者。除β2-微球蛋白外,所测量的所有蛋白质在糖尿病患者尿液中的排泄量均显著高于对照组。转铁蛋白检测最为敏感(阳性率58%),其次是白蛋白(49%)、免疫球蛋白G(34%)、血红素结合蛋白(28%)和视黄醇结合蛋白(26%)。仅考虑I型糖尿病患者时,得到了几乎相同的排序。糖尿病患者红细胞膜负电荷减少,且与白蛋白尿排泄量呈负相关(r = -0.61,n = 190)。红细胞电荷也与其他高分子量尿蛋白呈负相关(r在-0.5至-0.2之间),但与尿β2-微球蛋白或视黄醇结合蛋白无关。糖尿病患者红细胞电荷的丧失很可能反映了肾小球多阴离子的同时消耗,这导致高分子量血浆蛋白肾小球滤过增加。转铁蛋白排泄的优先增加以及免疫球蛋白G尿排泄的逐渐上升,使我们推测糖尿病中肾小球多阴离子的丧失从早期开始就伴随着肾小球滤过器大小选择性的逐渐降低。视黄醇结合蛋白的尿排泄量与白蛋白尿呈弱相关(r = 0.26,n = 186)。8%的糖尿病患者尿视黄醇结合蛋白升高,但无微量白蛋白尿证据,这清楚地表明在糖尿病肾病过程中近端肾小管损伤可独立于肾小球改变而发生。